These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3709808

  • 1. Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds.
    Brossi A, Schönenberger B, Clark OE, Ray R.
    FEBS Lett; 1986 Jun 09; 201(2):190-2. PubMed ID: 3709808
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ, Bian HL, Wang JW, Shan WG.
    Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1532-4. PubMed ID: 20144867
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.
    Atack JR, Yu QS, Soncrant TT, Brossi A, Rapoport SI.
    J Pharmacol Exp Ther; 1989 Apr 01; 249(1):194-202. PubMed ID: 2709330
    [Abstract] [Full Text] [Related]

  • 5. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
    Yu Q, Greig NH, Holloway HW, Brossi A.
    J Med Chem; 1998 Jun 18; 41(13):2371-9. PubMed ID: 9632370
    [Abstract] [Full Text] [Related]

  • 6. Effects of hexamethonium, phenothiazines, propranolol and ephedrine on acetylcholinesterase carbamylation by physostigmine, aldicarb and carbaryl: interaction between the active site and the functionally distinct peripheral sites in acetylcholinesterase.
    Singh AK, Spassova D.
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Jan 18; 119(1):97-105. PubMed ID: 9568379
    [Abstract] [Full Text] [Related]

  • 7. Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine.
    Galli A, Renzi G, Grazzini E, Bartolini R, Aiello-Malmberg P, Bartolini A.
    Biochem Pharmacol; 1982 Apr 01; 31(7):1233-8. PubMed ID: 7092918
    [Abstract] [Full Text] [Related]

  • 8. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
    De Sarno P, Pomponi M, Giacobini E, Tang XC, Williams E.
    Neurochem Res; 1989 Oct 01; 14(10):971-7. PubMed ID: 2608162
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of acetylcholinesterase by physostigmine analogs: conformational mobility of cysteine loop due to the steric effect of the alkyl chain.
    Gavuzzo E, Pomponi M.
    J Biochem Mol Toxicol; 2002 Oct 01; 16(2):64-9. PubMed ID: 11979423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine.
    Yu QS, Atack JR, Rapoport SI, Brossi A.
    J Med Chem; 1988 Dec 01; 31(12):2297-300. PubMed ID: 3193422
    [Abstract] [Full Text] [Related]

  • 13. Effect of cholinesterase inhibition in vitro by huperzine analogs.
    Tang XC, Xu H, Feng J, Zhou TX, Liu JS.
    Zhongguo Yao Li Xue Bao; 1994 Mar 01; 15(2):107-10. PubMed ID: 8010100
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.
    Kamal MA, Greig NH, Alhomida AS, Al-Jafari AA.
    Biochem Pharmacol; 2000 Aug 15; 60(4):561-70. PubMed ID: 10874131
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of acetylcholinesterase by new physostigmine derivatives.
    Marta M, Pomponi M.
    Biomed Biochim Acta; 1988 Aug 15; 47(3):285-8. PubMed ID: 3178795
    [Abstract] [Full Text] [Related]

  • 17. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
    Galli A, Malmberg Aiello P, Renzi G, Bartolini A.
    J Pharm Pharmacol; 1985 Jan 15; 37(1):42-8. PubMed ID: 2858526
    [Abstract] [Full Text] [Related]

  • 18. Comparison of (-)-eseroline with (+)-eseroline and dihydroseco analogues in antinociceptive assays: confirmation of rubreserine structure by X-ray analysis.
    Schönenberger B, Jacobson AE, Brossi A, Streaty R, Klee WA, Flippen-Anderson JL, Gilardi R.
    J Med Chem; 1986 Nov 15; 29(11):2268-73. PubMed ID: 3023611
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.